Epidemiological Profile of Hepatitis C patients treated at the Reference Services in the State of Piauí
DOI:
https://doi.org/10.33448/rsd-v9i6.3457Keywords:
Hepatitis C; Epidemiology; Treatment.Abstract
Hepatitis C is a global health problem and is a major cause of chronic liver disease on all continents. The objective of the article is to present the epidemiological profile of hepatitis C in the State of Piauí. This is a retrospective, cross-sectional and descriptive study with a quantitative and evaluative approach. Records and medical records were collected at SINAN, referring to patients diagnosed with the Hepatitis C Virus who were treated between 2014 and 2016 in the state of Piauí. The results obtained showed a prevalence of males, however, low education is equivalent for both sexes. The municipalities with the highest notifications were: Teresina (capital of the state), followed by Parnaíba, Piripiri and Picos. It was possible to identify the genotypes and their subtypes, type 1 (with subtypes 1a and 1b) being the most reported in the State, followed by genotype type 3. The transmission routes found were: parenteral, blood and sexual transfusion. As for treatment, it is observed that in 2014, the double therapy was performed with the drugs Peginterferonalfa and Ribavirin; in 2015 and 2016, the therapy was updated for Sufosbuvir, Simeprevir and Daclastavir, however, the treatments varied according to the identified genotype. It appears that between 2014 and 2016 there was a discrepancy between the notifications of the cases notified in SINAN and the registration of the number of patients in the medication dispensing, where this was shown to have the highest records. Data that should draw the attention of the State to the decentralization of notifications.
References
Ananthakrishnan, A. et al.(2010).Hepatitis C/HIV coinfection is associated with higher mortality in hospitalized patients with hepatitis C or HIV. Journalof Viral Hepatitis.17(1): 720-9.
Araújo, L. F. (2017). Alterações antropológicas decorrentes do tratamento de hepatite C crônica com interferon e ribavirina em pacientes com diferentes estadiamento de fibrose hepática.53f. Dissertação (mestrado). Universidade Estadual Paulista “Júlio de Mesquita Filho” Faculdade de Medicina de Botucatu. Botucatu.
Brasil (2018). Ministério da Saúde. Datasus. Informações de Saúde: Epidemiológicas e morbidade. Brasília: Ministério da Saúde, 2016a. Disponível em:<http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinannet/cnv/hepabr.def>. Acesso em: 05 abr. 2020.
Brasil (2017). Ministério da Saúde. Conitec. Protocolo Clínico e Diretrizes Terapêuticas para Hepatite C e Coinfecção: Relatório de Recomentação.Brasília: Ministério da Saúde, 2015.
Choo, Q. L. et al. (1989).Isolationof a cDNA clone derivedfrom a blood-borne non-A, non-B viral hepatitisgenome. Science. 244(1): 359-62.
Christos, C. et al. (2016).Epidemiology of hepatitis C in Greece.World J Gastroenterol,22(36): 8094-8102.
Bica, I. et al. (2001). Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.HIV/AIDS. 32(1): 492- 497.
Pawlotsky, J. M. et al (2015). Recommendation on treatment of hepatitis C.J Hepatol.63(1): 199-236.
Focaccia, R.(2013). Tratado de Hepatites Virais e Doenças Associadas. São Paulo: Atheneu.
Lavanchy, D. (2011). Evolving epidemiology of hepatitis C virus.ClinMicrobiol Infect.17(2): 107-15.
Lavanchy, D. (2009). The global burden of hepatitis C. Liver international. 29(1): 74-81.
WHO.(2014). Guidelines for the screening, care and treatment of persons with hepatitis C infection.Website of World Health Organization (WHO).
Moura, E. R. F. et al. (2012). Aspecto sexuais e perspectivas reprodutivas de mulheres com HIV/aids, o que mudou com a soropositividade. RevistaCubana de Enfermería. Fortaleza,28(1): 37-48.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.